Effect of Qingshen Granules on renal outcome in chronic kidney disease stage 3-4 patients with damp-heat syndrome and safety of Qingshen granules:a real-world multicenter, prospective cohort study

the First Affiliated Hospital of Anhui University of Traditional Chinese Medicine0 个研究点开始时间: 待定最近更新: 2023年2月20日

适应症

试验速览

暂无简介。

•1. Aged 18 to 70 years, male or female;
•2. Meet the diagnostic criteria of CKD stage 3a-4, as well as the syndrome differentiation criteria of TCM damp-heat syndrome;
•3. Blood pressure <140/90mmHg, serum potassium <5.5mmol/L, hemoglobin >=80g/L, infection under control, and stable condition for more than 2 weeks at the time of enrollment;
•4. Sign the informed consent.

•1. Pregnant or lactating patients;
•2. Unable to cooperate, such as mental patients;
•3. Combined with serious primary diseases such as active malignant tumor, decompensated liver cirrhosis or hematopoietic system;
•4. Patients with infectious diseases;
•5. There is acute urinary tract obstructive disease, requiring surgical treatment;
•6. Severe arrhythmia, severe heart failure, NYHA class III and above (evidence of New York Heart Association class III and IV), or myocardial infarction or cerebrovascular events within 3 months before enrollment;
•7. Are using corticosteroids, non-steroidal anti-inflammatory drugs or immunosuppressants;
•8. Those undergoing emergency hemodialysis;
•9. Those who have undergone kidney transplantation and total or partial parathyroidectomy;
•10. Those who are known to be allergic to or intolerable to a certain drug in this study; patients who are participating in other clinical trials.

发起方

the First Affiliated Hospital of Anhui University of Traditional Chinese Medicine